Selank is a synthetic heptapeptide analogue of the immunomodulatory peptide tuftsin, studied in research into neuropeptide and GABAergic signalling pathways in experimental models.
Selank is a synthetic heptapeptide derived from the endogenous immunopeptide tuftsin, with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It has the molecular formula C33H57N11O9, a molecular weight of 751.9 g/mol and CAS number 129954-34-3. Kyrolabs supplies it as a lyophilised powder for laboratory research use only, not for human or veterinary use.
Selank is not a controlled drug under the Misuse of Drugs Act 1971, so possessing the research material is not in itself prohibited. It is supplied for laboratory research use only and cannot be sold or marketed for human or veterinary consumption. It is not a licensed medicine and holds no UK marketing authorisation. The buyer is responsible for compliance in their jurisdiction.
No. Selank is supplied solely as a reference compound for non-clinical laboratory research. It is not intended, packaged or authorised for human or veterinary use, and no human or veterinary application is implied. It is not a licensed medicine and must not be consumed.
Selank has the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, a seven-residue heptapeptide. Its molecular formula is C33H57N11O9 and its molecular weight is 751.9 g/mol. These identifiers are confirmed against each batch certificate of analysis.
Selank has CAS number 129954-34-3 and is listed in PubChem under CID 11765600. The molecular formula is C33H57N11O9 with a molecular weight of 751.9 g/mol. The synonym TP-7 also refers to this compound. These identifiers let you verify identity independently against the batch documentation.
No. Purity and identity vary by supplier and batch, which is why a certificate of analysis matters. Kyrolabs releases each batch only after independent testing, with purity assessed by HPLC at 99% or higher and identity confirmed against the expected mass for CAS 129954-34-3. Batch documents are available on the certificates of analysis page.
Selank is supplied as a lyophilised white to off-white powder. For laboratory work it is reconstituted with a solvent such as bacteriostatic water. This is a research-bench preparation step and not a human-use instruction. The labelled vial strength is a product specification, not a dose.
Store the lyophilised solid at -20C, kept dry and protected from light. Once reconstituted, hold the material at 2-8C. Correct storage preserves peptide integrity for laboratory research. Selank is for laboratory research use only and not for human or veterinary use.
Selank is a peptide, specifically a synthetic heptapeptide analog of the immunopeptide tuftsin. It is not a steroid or a small-molecule drug. Its identity is defined by the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro and the molecular formula C33H57N11O9.
Selank and Semax are distinct synthetic peptides with different sequences and molecular identifiers; Selank is a tuftsin-derived heptapeptide (CAS 129954-34-3). Both are catalogued as research peptides in the neuropeptides category and supplied for laboratory research use only. Compare the two on their individual product pages and certificates of analysis.
Kyrolabs supplies Selank in the UK with batch certificate of analysis and UK despatch. It is sold for laboratory research use only and cannot be supplied for human or veterinary consumption. Browse the neuropeptides category for related research peptides.
Yes. Each batch of Selank is released after independent identity and purity testing, and a certificate of analysis documents the result. Purity is assessed by HPLC at 99% or higher and identity is confirmed against CAS 129954-34-3 and formula C33H57N11O9. Batch documents are listed on our certificates of analysis page.
No. Selank is not a licensed medicine and holds no marketing authorisation in the UK. It is a research chemical supplied for laboratory research use only. It is not intended to diagnose, treat, cure or prevent any condition, and no therapeutic claim is made.
Related
There are no reviews yet. Be the first to leave one.
KYRO supplies research-grade peptides for laboratory and in-vitro studies only. They are not medicines, hold no UK marketing authorisation, and are not presented to diagnose, treat, cure, prevent, or mitigate any condition. We do not provide therapeutic, dosing, or medical advice. By placing an order you confirm you are 18+ and acting as a qualified person in a research capacity.
Independent UK supplier of high-purity research peptides. Every batch HPLC-tested, cold-chain stored, and dispatched same-day from our Greater London facility.
© 2026 Kyrolabs Group Ltd.
